Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
BNT162b2 Approved by FDA Experimental Vaccine May/22/2021 48 0
ChAdOx1 nCoV-19 Emergency use authorization Experimental Vaccine May/22/2021 12 1
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Apr/23/2021 82 20
Convalescent plasma Emergency use authorization Experimental Antiviral Apr/10/2021 37 6
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Apr/10/2021 35 4
BBV152 Emergency use authorization Experimental Vaccine Mar/27/2021 7 0
Boceprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/01/2021 13 0
Hemin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/13/2021 1 1
Narlaprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/04/2021 3 0
Curcumin Potential treatment - theoretical effect Natural product Antiviral Feb/03/2021 6 0